Intravenous Methylprednisolone in Induction Therapy for ANCA-Associated Vasculitis: How Low Can We Go?

Oliva-Damaso, N., & Bomback, A. S. (2023). Intravenous Methylprednisolone in Induction Therapy for ANCA-Associated Vasculitis: How Low Can We Go? Kidney360, 4(9), e1199–e1200. https://doi.org/10.34067/kid.0000000000000257
Authors:
Néstor Oliva-Dámaso
Andrew S. Bomback
Affiliated Authors:
Andrew S. Bomback
Columbia Affiliation:
Subjects:
Methylprednisolone (MeSH)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (MeSH)
Classification and Management of Vasculitides (OpenAlex Topic)
Clinical Characteristics and Management of Sarcoidosis (OpenAlex Topic)
Pathophysiology of Glomerular Diseases and Nephrotic Syndromes (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.34067/kid.0000000000000257
PMID:
37768809
DOI:
10.34067/kid.0000000000000257
Journal:
Kidney360
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: